This Week in Nature | GenomeWeb

This Week in Nature

In Nature, a group from Massachusetts General Hospital presented details about new, high-fidelity CRISPR/Cas9 nuclease that enable targeted genome editing with no apparent off-target effects. The nuclease is designed to carry alterations that reduce non-specific DNA contacts, and when targeted to standard non-repetitive sequences, it rendered nearly all off-target events undetectable by genome-wide break capture and targeted sequencing methods.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.